Search Results - "Bartels, J. Michael"

Refine Results
  1. 1

    A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: Development and validation by Smith, Jordan Ned, Hinderliter, Paul M., Timchalk, Charles, Bartels, Michael J., Poet, Torka S.

    Published in Regulatory toxicology and pharmacology (01-08-2014)
    “…•A life-stage PBPK/PD model for chlorpyrifos was developed.•Simulations predict adults will have higher chlorpyrifos levels in blood.•At doses ⩾0.6mg/kg,…”
    Get full text
    Journal Article
  2. 2

    In Vitro Age-Dependent Enzymatic Metabolism of Chlorpyrifos and Chlorpyrifos-Oxon in Human Hepatic Microsomes and Chlorpyrifos-Oxon in Plasma by NED SMITH, Jordan, TIMCHALK, Charles, BARTELS, Michael J, POET, Torka S

    Published in Drug metabolism and disposition (01-08-2011)
    “…Age-dependent chlorpyrifos (CPF) metabolism was quantified by in vitro product formation in human hepatic microsomes (ages 13 days to 75 years) and plasma…”
    Get full text
    Journal Article
  3. 3

    Direct quantitation of hydroxyethylvaline in hemoglobin by liquid chromatography/positive electrospray tandem mass spectrometry by Zhang, Fagen, Brzak, Kathy A., Pottenger, Lynn H., Bartels, Michael J.

    Published in Journal of Chromatography A (27-07-2012)
    “…► We developed a rapid LC/MS–MS quantitation method for hydroxyvaline in globin. ► This method gave similar hydroxyvaline values compared to the traditional…”
    Get full text
    Journal Article
  4. 4

    Dose–response and operational thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive mutagens, MMS and MNU by Pottenger, Lynn H., Schisler, Melissa R., Zhang, Fagen, Bartels, Michael J., Fontaine, Donald D., McFadden, Lisa G., Bhaskar Gollapudi, B.

    Published in Mutation research (01-08-2009)
    “…The dose–response relationships for in vitro mutagenicity induced by methylmethanesulfonate (MMS) or methylnitrosourea (MNU) in L5178Y mouse lymphoma (ML)…”
    Get full text
    Journal Article
  5. 5

    Development of a source-to-outcome model for dietary exposures to insecticide residues: An example using chlorpyrifos by Hinderliter, Paul M., Price, Paul S., Bartels, Michael J., Timchalk, Charles, Poet, Torka S.

    Published in Regulatory toxicology and pharmacology (01-10-2011)
    “…► Source-to-outcome model for inter-individual variation at dietary dose levels. ► Differences in physiology and variation in metabolism included at ages 3 and…”
    Get full text
    Journal Article
  6. 6

    The Effect of Plasma Lipids on the Pharmacokinetics of Chlorpyrifos and the Impact on Interpretation of Blood Biomonitoring Data by Lowe, Ezra R., Poet, Torka S., Rick, David L., Marty, M. Sue, Mattsson, Joel L., Timchalk, Charles, Bartels, Michael J.

    Published in Toxicological sciences (01-04-2009)
    “…Lipophilic molecules, like chlorpyrifos (CPF), present a special problem for interpretation of biomonitoring data because both the environmental dose of CPF…”
    Get full text
    Journal Article
  7. 7

    Biomonitoring of 2,4-Dichlorophenoxyacetic Acid Exposure and Dose in Farm Families by Alexander, Bruce H., Mandel, Jack S., Baker, Beth A., Burns, Carol J., Michael J. Bartels, Acquavella, John F., Gustin, Christophe

    Published in Environmental health perspectives (01-03-2007)
    “…Objective: We estimated 2,4-dichlorophenoxyacetic acid (2,4-D) exposure and systemic dose in farm family members following an application of 2,4-D on their…”
    Get full text
    Journal Article
  8. 8

    Social Exclusion Decreases Prosocial Behavior by Twenge, Jean M, Baumeister, Roy F, DeWall, C. Nathan, Ciarocco, Natalie J, Bartels, J. Michael

    “…In 7 experiments, the authors manipulated social exclusion by telling people that they would end up alone later in life or that other participants had rejected…”
    Get full text
    Journal Article
  9. 9

    Dynamic Changes in Lipids and Proteins of Maternal, Fetal, and Pup Blood and Milk during Perinatal Development in CD and Wistar Rats by McMullin, Tami S., Lowe, Ezra R., Bartels, Michael J., Marty, Mary Sue

    Published in Toxicological sciences (01-10-2008)
    “…An understanding of the physiological factors that regulate perinatal dosimetry is essential to improve the ability of physiologically based (PB)…”
    Get full text
    Journal Article
  10. 10

    Quantitation of 4,4'-methylene diphenyl diisocyanate human serum albumin adducts by Luna, Leah G, Green, Brett J, Zhang, Fagen, Arnold, Scott M, Siegel, Paul D, Bartels, Michael J

    Published in Toxicology reports (01-01-2014)
    “…4,4'-Methylene diphenyl diisocyanate (herein 4,4'-MDI) is used in the production of polyurethane foams, elastomers, coatings, adhesives and the like for a wide…”
    Get full text
    Journal Article
  11. 11

    Metabolic Basis for Nonlinearity in 1,3-Dichloropropene Toxicokinetics and Use in Setting a Kinetically-derived Maximum Inhalation Exposure Concentration in Mice by Bartels, Michael J, Hackett, Michael J, Himmelstein, Matthew W, Green, John W, Walker, Carl, Terry, Claire, Rasoulpour, Reza, Challender, Mary, Yan, Zhongyu (June)

    Published in Toxicological sciences (01-03-2020)
    “…Abstract 1,3-Dichloropropene (1,3-D) showed a statistically increased incidence of bronchioloalveolar adenomas in male B6C3F1 mice at 60 ppm air concentration…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability by Bhhatarai, Barun, Wilson, Daniel M, Bartels, Michael J, Chaudhuri, Shubhra, Price, Paul S, Carney, Edward W

    Published in Toxicological sciences (01-10-2015)
    “…There is great interest in assessing the in vivo toxicity of chemicals using nonanimal alternatives. However, acute mammalian toxicity is not adequately…”
    Get full text
    Journal Article
  14. 14

    Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment by Troutman, John A., Rick, David L., Stuard, Sharon B., Fisher, Jeffrey, Bartels, Michael J.

    Published in Regulatory toxicology and pharmacology (01-11-2015)
    “…2-Phenoxyethanol (PhE) has been shown to induce hepatotoxicity, renal toxicity, and hemolysis at dosages ≥ 400 mg/kg/day in subchronic and chronic studies in…”
    Get full text
    Journal Article
  15. 15

    PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data by Cooper, Alexander B., Aggarwal, Manoj, Bartels, Michael J., Morriss, Alistair, Terry, Claire, Lord, Gwyn A., Gant, Timothy W.

    Published in Regulatory toxicology and pharmacology (01-03-2019)
    “…Physiologically-based toxicokinetic (PBTK) models are mathematical representations of chemical absorption, distribution, metabolism and excretion (ADME) in…”
    Get full text
    Journal Article
  16. 16

    Chlorpyrifos PBPK/PD model for multiple routes of exposure by Poet, Torka S., Timchalk, Charles, Hotchkiss, Jon A., Bartels, Michael J.

    Published in Xenobiotica (01-10-2014)
    “…Abstract 1. Chlorpyrifos (CPF) is an important pesticide used to control crop insects. Human Exposures to CPF will occur primarily through oral exposure to…”
    Get full text
    Journal Article
  17. 17

    Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos by Poet, Torka S., Timchalk, Charles, Bartels, Michael J., Smith, Jordan N., McDougal, Robin, Juberg, Daland R., Price, Paul S.

    Published in Regulatory toxicology and pharmacology (01-06-2017)
    “…A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model combined with Monte Carlo analysis of inter-individual variation was used to assess…”
    Get full text
    Journal Article
  18. 18

    Dose-Response for Multiple Biomarkers of Exposure and Genotoxic Effect Following Repeated Treatment of Rats with the Alkylating Agents, MMS and MNU by Ji, Zhiying, LeBaron, Matthew J, Schisler, Melissa R, Zhang, Fagen, Bartels, Michael J, Gollapudi, B Bhaskar, Pottenger, Lynn H

    Published in Mutagenesis (01-05-2016)
    “…The nature of the dose-response relationship for various in vivo endpoints of exposure and effect were investigated using the alkylating agents, methyl…”
    Get full text
    Journal Article
  19. 19
  20. 20